Northern Trust’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8K | Hold |
43,196
| – | – | ﹤0.01% | 4245 |
|
|
2025
Q1 | $58.7K | Hold |
43,196
| – | – | ﹤0.01% | 4209 |
|
|
2024
Q4 | $59.6K | Buy |
43,196
+10,601
| +33% | +$14.6K | ﹤0.01% | 4241 |
|
|
2024
Q3 | $34.9K | Hold |
32,595
| – | – | ﹤0.01% | 4268 |
|
|
2024
Q2 | $70.1K | Sell |
32,595
-3,768
| -10% | -$8.1K | ﹤0.01% | 4136 |
|
|
2024
Q1 | $118K | Buy |
36,363
+3,313
| +10% | +$10.8K | ﹤0.01% | 4033 |
|
|
2023
Q4 | $677K | Buy |
33,050
+16,415
| +99% | +$336K | ﹤0.01% | 3442 |
|
|
2023
Q3 | $267K | Buy |
+16,635
| New | +$267K | ﹤0.01% | 3710 |
|
|
2023
Q2 | – | Sell |
-76,134
| Closed | -$751K | – | 4535 |
|
|
2023
Q1 | $751K | Sell |
76,134
-4,684
| -6% | -$46.2K | ﹤0.01% | 3314 |
|
|
2022
Q4 | $770K | Buy |
80,818
+43,379
| +116% | +$413K | ﹤0.01% | 3355 |
|
|
2022
Q3 | $650K | Buy |
37,439
+1,042
| +3% | +$18.1K | ﹤0.01% | 3427 |
|
|
2022
Q2 | $282K | Buy |
+36,397
| New | +$282K | ﹤0.01% | 3750 |
|